Quoin Pharmaceuticals (QNRX) Long-Term Debt Issuances (2020 - 2026)

Quoin Pharmaceuticals has reported Long-Term Debt Issuances for 6 years, with the latest figure at $150000.0 in Q1 2026.

• Quarterly Long-Term Debt Issuances changed 0.0% year-over-year to $150000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $450000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $600000.0, changed 0.0% from the prior year.
• Long-Term Debt Issuances steadied at $150000.0 in Q1 2026 per QNRX's latest filing, from $150000.0 in the prior quarter.
• Over five years, Long-Term Debt Issuances peaked at $200000.0 in Q3 2023 and troughed at $75000.0 in Q2 2022.
• A 5-year average of $119117.6 and a median of $150000.0 in 2022 frame the typical range for Long-Term Debt Issuances.
• The sharpest annual moves came in 2023 and 2024: Long-Term Debt Issuances jumped 166.67% in 2023, then plunged 62.5% in 2024.
• Over 5 years, Long-Term Debt Issuances stood at $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then changed by 0.0% to $150000.0 in 2024, then changed by 0.0% to $150000.0 in 2025, then changed by 0.0% to $150000.0 in 2026.
• According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $150000.0, $150000.0, and $75000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.